Prosidion Limited
Patent Applications and Registrations
Patent applications and USPTO patent grants for Prosidion Limited.The latest application filed is for "aryl urea derivatives for treating obesity".
- Prosidion Limited - Oxford GB
- PROSIDION LIMITED - Oxford, Oxfordshire GB
- PROSIDION LIMITED - Oxford Oxforshire GB
- PROSIDION LIMITED - Osford, Oxfordshire GB
- Prosidion Ltd. - Oxford GB
| Patent | Date |
|---|---|
| Pyrrolopyridine-2-carboxylic acid amide derivative useful as inhibitor of glycogen phosphorylase Grant 8,664,397 - Repasi , et al. March 4, 2 | 2014-03-04 |
| Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders Grant 8,278,442 - Bloxham , et al. October 2, 2 | 2012-10-02 |
| Aryl Urea Derivatives for Treating Obesity App 20120214808 - Bloxham; Jason ; et al. | 2012-08-23 |
| GPCR Agonists App 20120172358 - Bradley; Stuart Edward ; et al. | 2012-07-05 |
| Heterocyclic derivatives as GPCR receptor agonists Grant 8,207,147 - Fyfe , et al. June 26, 2 | 2012-06-26 |
| G-protein coupled receptor agonists Grant 8,193,359 - Fyfe , et al. June 5, 2 | 2012-06-05 |
| Pyridine, pyrimidine and pyrazine derivatives as GPCR agonists Grant 8,173,807 - Bradley , et al. May 8, 2 | 2012-05-08 |
| Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase Grant 8,158,622 - Bradley , et al. April 17, 2 | 2012-04-17 |
| Compounds for the Treatment of Metabolic Disorders App 20120077793 - Barba; Oscar ; et al. | 2012-03-29 |
| Compounds for the Treatment of Metabolic Disorders App 20120059014 - Barba; Oscar ; et al. | 2012-03-08 |
| Compounds for the Treatment of Metabolic Disorders App 20120040953 - Barba; Oscar ; et al. | 2012-02-16 |
| Bicyclic aryl and heteroaryl receptor modulators Grant 8,063,247 - Bloxham , et al. November 22, 2 | 2011-11-22 |
| Piperidinyl Gpcr Agonists App 20110269734 - Bertram; Lisa Sarah ; et al. | 2011-11-03 |
| Piperidine GPCR Agonists App 20110230507 - Bertram; Lisa Sarah ; et al. | 2011-09-22 |
| Heterocyclic GPCR Agonists App 20110212939 - Bertram; Lisa Sarah ; et al. | 2011-09-01 |
| Piperidinyl GPCR Agonists App 20110195994 - Bertram; Lisa Sarah ; et al. | 2011-08-11 |
| Heterocyclic GPCR Agonists App 20110178054 - Bertram; Lisa Sarah ; et al. | 2011-07-21 |
| Substituted phenylacetamides and their use as glucokinase activators Grant 7,745,491 - Fyfe , et al. June 29, 2 | 2010-06-29 |
| Amide And Urea Derivatives For The Treatment Of Metabolic Diseases App 20100093733 - Barba; Oscar ; et al. | 2010-04-15 |
| Heterocyclic Derivatives As Gpcr Receptor Agonists App 20090281060 - Fyfe; Matthew ; et al. | 2009-11-12 |
| Tri(cyclo) substituted amide compounds Grant 7,582,632 - Fyfe , et al. September 1, 2 | 2009-09-01 |
| Indole-2-Carboxylic Acid Hydrazides App 20080188472 - Bradley; Stuart Edward ; et al. | 2008-08-07 |
| Tri(cyclo) substituted amide glucokinase activator compounds Grant 7,262,196 - Fyfe , et al. August 28, 2 | 2007-08-28 |
| Tri(cyclo) substituted amide compounds Grant 7,214,681 - Fyfe , et al. May 8, 2 | 2007-05-08 |
| Prodrugs of DP IV-inhibitors Grant 7,166,579 - Demuth , et al. January 23, 2 | 2007-01-23 |
| Methods for identification of modulators of OSGPR116 activity Grant 7,083,933 - Griffin August 1, 2 | 2006-08-01 |
| Glutaminyl based DPIV inhibitors Grant 7,060,719 - Demuth , et al. June 13, 2 | 2006-06-13 |
| Compounds of unstable DP IV-inhibitors Grant 7,053,055 - Demuth , et al. May 30, 2 | 2006-05-30 |
| Methods for improving islet signaling in diabetes mellitus and for its prevention Grant 6,890,905 - Demuth , et al. May 10, 2 | 2005-05-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 